# JDOC holdings: all 57 positions

> All 57 JDOC holdings with weights, as of Oct 14, 2026. The top 3 are ABBV 8.76%, LLY 8.06% and UNH 5.65%. Download the full list as a CSV.

Data as of Oct 14, 2026. Rebuilt every trading night.

JDOC held 57 positions as of Oct 14, 2026. AbbVie Inc is the largest at 8.76%; the top 10 are 51.1% of the fund.

Source: am.jpmorgan.com (https://am.jpmorgan.com/FundsMarketingHandler/product-data?cusip=46654Q765&country=us&role=adv&language=en&userLoggedIn=false).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | AbbVie Inc | ABBV | 8.76% |
| 2 | Eli Lilly & Co | LLY | 8.06% |
| 3 | UnitedHealth Group Inc | UNH | 5.65% |
| 4 | Merck & Co Inc | MRK | 4.94% |
| 5 | Johnson & Johnson | JNJ | 4.67% |
| 6 | Thermo Fisher Scientific Inc | TMO | 4.56% |
| 7 | Novartis AG Common Stock | NOVN | 4.55% |
| 8 | Astrazeneca PLC Common | AZN | 3.95% |
| 9 | Danaher Corp | DHR | 2.99% |
| 10 | Abbott Laboratories | ABT | 2.97% |
| 11 | Novo Nordisk A/S Common | NOVOB | 2.50% |
| 12 | IQVIA Holdings Inc | IQV | 2.22% |
| 13 | Cencora Inc | COR | 2.21% |
| 14 | Humana Inc | HUM | 2.05% |
| 15 | Argenx SE Common Stock | ARGX | 1.95% |
| 16 | Takeda Pharmaceutical Co |  | 1.90% |
| 17 | Biogen Inc | BIIB | 1.88% |
| 18 | Bristol-Myers Squibb Co | BMY | 1.86% |
| 19 | Roche Holding AG Common | ROP | 1.82% |
| 20 | Regeneron Pharmaceuticals Inc | REGN | 1.80% |
| 21 | Edwards Lifesciences Corp | EW | 1.72% |
| 22 | Teva Pharmaceutical Industries Ltd | TEVA | 1.57% |
| 23 | Bayer AG Common Stock | BAYN | 1.48% |
| 24 | Centene Corp | CNC | 1.48% |
| 25 | Vertex Pharmaceuticals Inc | VRTX | 1.41% |
| | Cash and other net assets | | 1.37% |

The largest 25 of 57 positions are shown. All of them: https://etfiq.com/funds/jdoc/holdings/jdoc-holdings.csv (CSV) or https://etfiq.com/data/books/jdoc.json (JSON).

Fund page: https://etfiq.com/funds/jdoc

Cite: ETFIQ, Holdings of JDOC, data as of Oct 14, 2026. https://etfiq.com/funds/jdoc/holdings/